Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**High molecular weight sodium hyaluronate** is the sodium salt form of hyaluronic acid, a long-chain glycosaminoglycan naturally present in human connective tissues. High molecular weight formulations, such as the one found in ORTHOVISC, possess a viscoelastic property permitting their use as intra-articular injections for supplementation of synovial fluid, leading to improved joint lubrication and shock absorption. The mechanism involves providing mechanical support and possibly modulating the inflammatory response in the joint. ORTHOVISC contains sodium hyaluronate extracted from rooster combs, with a molecular weight ranging from 1 to 2.9 million daltons, delivered as a 15 mg/mL solution for injection[1]. Its primary indication is pain management in osteoarthritis of the knee in patients unresponsive to conservative therapies[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on high molecular weight sodium hyaluronate.